• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 98 páginas
Examen

BCPS Pharmacotherapy Recertification Exam 2026: Professional Practice Test — Patient-Specific Therapy, Evidence-Based Medicine, Drug Information & Population Health — 190 Multiple-Choice Questions with Answers & Detailed Rationales

Document preview thumbnail
Vista previa 4 fuera de 98 páginas

BCPS Pharmacotherapy Recertification Exam 2026: Professional Practice Test — Patient-Specific Therapy, Evidence-Based Medicine, Drug Information & Population Health — 190 Multiple-Choice Questions with Answers & Detailed Rationales

Vista previa del contenido

BCPS Pharmacotherapy Certification Exam 2026: Comprehensive
Board Practice Test — Clinical Pharmacotherapy, Disease State
Management, Drug Selection, Medication Safety & Evidence-Based
Clinical Decision-Making — 190+ Multiple-Choice Questions with
Answers & Detailed Rationales




SECTION 1: INFECTIOUS DISEASES (Questions 1–22)

Question 1



A 58-year-old male presents to the emergency department with fever, neck stiffness, and
altered mental status. He is empirically started on vancomycin, ceftriaxone, and ampicillin.
Which additional agent should be administered concomitantly with the first antibiotic dose?



A. Acyclovir

B. Dexamethasone

C. Mannitol

D. Phenytoin



Correct Answer: B



Explanation: Adjunctive dexamethasone reduces mortality in bacterial meningitis by
decreasing inflammatory response from bacteriolysis; administer with or just before first
antibiotic dose.



Question 2



Which antimicrobial spectrum best describes the role of ampicillin in empiric meningitis
coverage for patients over 50 years?

,A. Methicillin-resistant Staphylococcus aureus

B. Listeria monocytogenes

C. Pseudomonas aeruginosa

D. Neisseria meningitidis



Correct Answer: B



Explanation: Ampicillin is added for patients >50 years or immunocompromised to cover
Listeria monocytogenes, which ceftriaxone and vancomycin do not adequately target.



Question 3



A 72-year-old female is diagnosed with bacterial meningitis. She has a documented severe
penicillin allergy (anaphylaxis). What is the most appropriate alternative for Listeria
coverage?



A. Trimethoprim-sulfamethoxazole

B. Meropenem

C. Ciprofloxacin

D. Gentamicin



Correct Answer: A



Explanation: TMP-SMX is the preferred alternative for Listeria coverage in patients with
severe penicillin allergy; meropenem has cross-reactivity risk.



Question 4

,Which antifungal prophylaxis is indicated for a patient with HIV and CD4 count <200
cells/mm³ who is initiating antiretroviral therapy immediately?



A. Azithromycin

B. Fluconazole

C. Trimethoprim-sulfamethoxazole

D. Atovaquone



Correct Answer: C



Explanation: TMP-SMX DS daily prevents both Pneumocystis jirovecii pneumonia and
toxoplasmosis in at-risk HIV patients; prophylaxis continues until CD4 >200 for 3 months.



Question 5



A patient with HIV has a CD4 count of 45 cells/mm³ and is not yet on antiretroviral therapy.
Which prophylaxis is indicated for Mycobacterium avium complex?



A. Azithromycin 1200 mg weekly

B. Rifabutin 300 mg daily

C. Clarithromycin 500 mg twice daily

D. Both A and C are appropriate



Correct Answer: A



Explanation: MAC prophylaxis is indicated when CD4 <50 cells/mm³ and ART is not
immediately initiated; azithromycin 1200 mg weekly is first-line.



Question 6

, A 45-year-old male with HIV and a sulfa allergy (rash) requires Pneumocystis jirovecii
prophylaxis. What is the most appropriate alternative?



A. Dapsone

B. Atovaquone

C. Pentamidine

D. All of the above are options



Correct Answer: B



Explanation: Atovaquone is preferred for mild sulfa reactions; dapsone has sulfonamide
cross-reactivity, and pentamidine is second-line due to toxicity.



Question 7



Which antimicrobial agent demonstrates concentration-dependent killing and requires
therapeutic drug monitoring for both efficacy and toxicity?



A. Vancomycin

B. Gentamicin

C. Meropenem

D. Linezolid



Correct Answer: B



Explanation: Aminoglycosides exhibit concentration-dependent killing; AUC/MIC or
peak/trough monitoring minimizes nephrotoxicity and ototoxicity.

Información del documento

Subido en
15 de octubre de 2026
Número de páginas
98
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$24.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
0
Seguidores
0
Artículos
305
Última venta
-



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes